Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics
UNCY Price/Volume Stats
| Current price | $4.58 | 52-week high | $11.00 |
| Prev. close | $4.62 | 52-week low | $2.02 |
| Day low | $4.44 | Volume | 632,700 |
| Day high | $4.72 | Avg. volume | 354,742 |
| 50-day MA | $6.03 | Dividend yield | N/A |
| 200-day MA | $5.85 | Market Cap | 57.90M |
UNCY Stock Price Chart Interactive Chart >
Unicycive Therapeutics, Inc., (UNCY) Company Bio
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
UNCY Price Returns
| 1-mo | -39.28% |
| 3-mo | -23.70% |
| 6-mo | -26.13% |
| 1-year | -2.97% |
| 3-year | -42.79% |
| 5-year | N/A |
| YTD | -42.33% |
| 2024 | -8.47% |
| 2023 | 60.69% |
| 2022 | -73.79% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...